Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 10-2019 | 09-2019 | 07-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,134 | -29,127 | -23,349 | -20,045 | -14,055 |
| Depreciation Amortization | 450 | 1,638 | 1,301 | 1,342 | 885 |
| Income taxes - deferred | N/A | N/A | N/A | -120 | N/A |
| Accounts receivable | -1,246 | 5,439 | 5,187 | 2,750 | 3,714 |
| Accounts payable and accrued liabilities | 2,696 | -1,306 | -2,225 | -521 | -3,146 |
| Other Working Capital | 287 | 2,009 | -1,219 | 1,700 | -37 |
| Other Operating Activity | -1,012 | 590 | 3,941 | 1,033 | 3,856 |
| Operating Cash Flow | $-4,959 | $-20,757 | $-16,365 | $-13,861 | $-8,783 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -205 | -160 | -247 | -150 |
| Purchase Sale Intangibles | -164 | -136 | -128 | -111 | -127 |
| Other Investing Activity | -164 | -136 | -124 | -111 | -124 |
| Investing Cash Flow | $-194 | $-341 | $-284 | $-358 | $-274 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3 | 50,417 | 1 | 25,081 | 1 |
| Other Financing Activity | 0 | -912 | -332 | -577 | -227 |
| Financing Cash Flow | $3 | $49,505 | $-331 | $24,504 | $-226 |
| Exchange Rate Effect | -3,749 | 190 | 555 | -787 | 1,687 |
| Beginning Cash Position | 63,842 | 35,245 | 33,277 | 12,138 | 34,045 |
| End Cash Position | 54,943 | 63,842 | 16,853 | 21,636 | 26,450 |
| Net Cash Flow | $-8,899 | $28,597 | $-16,424 | $9,498 | $-7,596 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,959 | -20,757 | -16,365 | -13,861 | -8,783 |
| Capital Expenditure | -30 | -205 | -160 | -247 | -150 |
| Free Cash Flow | -4,989 | -20,962 | -16,525 | -14,108 | -8,933 |